Christine Juergens

Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO‐E.W.I.N.G. 99 clinical trial

Christine Juergens, Claire Weston, Ian Lewis et al. · Pediatric Blood & Cancer · 2006 · 276 citations

Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial

Ron Dagan, Scott D. Patterson, Christine Juergens et al. · Clinical Infectious Diseases · 2013 · 246 citations · Full text

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

Dorothee Kieninger, Kathrin Kueper, Katrin Steul et al. · Vaccine · 2010 · 168 citations

Vaccinology, Vaccine Safety, Vaccination +8

Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study

Catherine Cordonnier, Per Ljungman, Christine Juergens et al. · Clinical Infectious Diseases · 2015 · 102 citations · Full text

Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-Nonsusceptible<i>Streptococcus pneumoniae</i>

Ron Dagan, Christine Juergens, James Trammel et al. · The Journal of Infectious Diseases · 2014 · 75 citations · Full text